Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma nejmoa1817249 RETOUR MarcGuevreguian2021-03-23T11:23:36+01:00